Lili Yang

Lili Yang, Ph.D., is an associate professor of microbiology, immunology, and molecular genetics at UCLA. Her lab is focused on developing gene- and cell-based cancer immunotherapies and she was an integral inventor of Appia’s ACUA technology platform. Previously, Dr. Yang was involved in the scientific founding of Immune Design. She is the recipient of numerous awards: Outstanding New Investigator Award by the American Society of Gene and Cell Therapy; Director’s New Innovator Award from the National Institutes of Health; and, TR35 (Innovators Under 35) Award from the Massachusetts Institute of Technology Review Magazine. Dr. Yang earned her PhD in biology from Caltech studying with Dr. Baltimore.